As India’s securities regulator ramps up scrutiny of the options market, some investors are pointing to mysterious moves in ...

Indian equity benchmarks posted a second straight weekly loss, weighed down by uncertainty over a potential U.S. trade deal ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

India's benchmark shares were muted on Tuesday after U.S. President Donald Trump delayed implementation of tariffs to August ...

The Nifty50 delivered an 8.5% return in Q1, while mid and small-cap stocks outperformed with a 10.7% gain, rebounding from a ...

India's equity benchmarks are expected to open little changed on Wednesday, with investor caution deepening after U.S.

The Invesco India ETF offers exposure to slightly higher quality Indian stocks. Read why I rate Indian equities as a Buy but ...

Gift Nifty was trading around 25,179 level, a discount of nearly 12.5 points from the Nifty futures’ previous close, ...

Not everyone agrees on the prospects for artificial intelligence, but there’s near unanimity on the likelihood of a boom in ...

Boeing stock fell Thursday as investors waited for details from flight data recorders from Air India flight 171, which ...

With the stock trading lower in Monday's session, it is currently among the top losers on the Nifty Midcap 150.

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...